Published in Proc Natl Acad Sci U S A on February 01, 1993
The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res (2006) 4.38
A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA. Genes Dev (2000) 2.98
Mechanisms of ischemic brain damage. Neuropharmacology (2008) 2.40
Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype. Proc Natl Acad Sci U S A (1993) 1.64
Hypoxia-inducible factor 1alpha stabilization by carbon monoxide results in cytoprotective preconditioning. Proc Natl Acad Sci U S A (2007) 1.61
Medical applications of transforming growth factor-beta. Clin Med Res (2003) 0.97
Good and bad sides of TGFβ-signaling in myocardial infarction. Front Physiol (2015) 0.88
Cold ischemia induces isograft arteriopathy, but does not augment allograft arteriopathy in non-immunosuppressed hosts. Am J Pathol (2002) 0.87
Isoflurane post-conditioning protects against intestinal ischemia-reperfusion injury and multiorgan dysfunction via transforming growth factor-β1 generation. Ann Surg (2012) 0.86
Role of tumour necrosis factor-alpha and other cytokines in ischemia-reperfusion-induced injury in the heart. Exp Clin Cardiol (2005) 0.83
Specific binding of endocrine transforming growth factor-beta 1 to vascular endothelium. J Clin Invest (1995) 0.83
Enhancement of the haemodynamic effects of NG-monomethyl-L-arginine by transforming growth factor-beta 1 in conscious, normal, but not endotoxaemic, rats. Br J Pharmacol (1995) 0.75
Mechanisms of cell death in acute myocardial infarction: pathophysiological implications for treatment. Neth Heart J (2001) 0.75
The role of transforming growth factor (TGF)-β in the infarcted myocardium. J Thorac Dis (2017) 0.75
Usefulness of circulating E-selectin to early detection of the atherosclerotic process in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Diabetol Metab Syndr (2016) 0.75
Anti-inflammatory Effects of Valproic Acid in a Rat Model of Renal Ischemia/Reperfusion Injury: Alteration in Cytokine Profile. Inflammation (2017) 0.75
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (1987) 35.44
Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol (1982) 10.99
Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci U S A (1987) 10.43
Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem (1983) 9.32
Endothelium-derived relaxing and contracting factors. FASEB J (1989) 7.22
Biosynthesis of nitric oxide from L-arginine. A pathway for the regulation of cell function and communication. Biochem Pharmacol (1989) 6.87
Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J Clin Invest (1989) 5.97
Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol (1987) 5.23
Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol (1986) 4.88
Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods (1985) 3.67
Purification and initial characterization of a type beta transforming growth factor from human placenta. Proc Natl Acad Sci U S A (1983) 3.52
Purification and properties of a type beta transforming growth factor from bovine kidney. Biochemistry (1983) 3.49
Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin. J Biol Chem (1987) 2.15
Endothelial adhesiveness for blood neutrophils is inhibited by transforming growth factor-beta. Science (1988) 2.11
Cellular receptors for type beta transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines. J Biol Chem (1985) 1.96
Hepatic processing of transforming growth factor beta in the rat. Uptake, metabolism, and biliary excretion. J Clin Invest (1987) 1.88
Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB J (1991) 1.55
Mediation of cardioprotection by transforming growth factor-beta. Science (1990) 1.52
Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion. J Clin Invest (1991) 1.48
Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation (1992) 1.40
Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation (1990) 1.31
Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion. J Pharmacol Exp Ther (1990) 1.26
GMP-140: a receptor for neutrophils and monocytes on activated platelets and endothelium. J Cell Biochem (1991) 1.16
Anti-EDRF effect of tumor necrosis factor in isolated, perfused cat carotid arteries. Am J Physiol (1989) 1.11
A method for isolation and fluorescent labeling of rat neutrophils for intravital microvascular studies. Microvasc Res (1990) 0.98
Neutrophil-mediated vasoconstriction and endothelial dysfunction in low-flow perfusion-reperfused cat coronary artery. Circ Res (1991) 0.97
Mechanisms of the protective effects of transforming growth factor-beta in reperfusion injury. Biochem Pharmacol (1991) 0.89
Endothelium and myocardial protecting actions of taprostene, a stable prostacyclin analogue, after acute myocardial ischemia and reperfusion in cats. Circ Res (1990) 0.85
Demonstration of depressed polymorphonuclear leukocyte function in nonviremic FeLV-infected cats. Cancer Invest (1986) 0.84
Beneficial effects of transforming growth factor-beta and tissue plasminogen activator in splanchnic artery occlusion and reperfusion in cats. J Cardiovasc Pharmacol (1991) 0.83
Low doses of superoxide dismutase and a stable prostacyclin analogue protect in myocardial ischemia and reperfusion. J Am Coll Cardiol (1992) 0.80
The role of neutrophils in vascular injury: a summary of signal transduction mechanisms in cell/cell interactions. Springer Semin Immunopathol (1989) 0.79
Cardiac venous endothelial dysfunction after myocardial ischemia and reperfusion in dogs. Am J Physiol (1992) 0.78
AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. Am J Pathol (2001) 2.81
Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol (2001) 2.75
Platelet functions beyond hemostasis. J Thromb Haemost (2009) 2.23
Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling. J Virol (2001) 2.07
Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking. J Clin Invest (1997) 1.87
Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice. Am J Physiol (1999) 1.72
Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res (1993) 1.63
Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts. Circulation (1999) 1.62
Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB J (1991) 1.55
Activated neutrophils aggravate endothelial dysfunction after reperfusion of the ischemic feline myocardium. Am Heart J (1992) 1.53
Engagement of P-selectin glycoprotein ligand-1 enhances tyrosine phosphorylation and activates mitogen-activated protein kinases in human neutrophils. J Biol Chem (1997) 1.48
Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats. Arterioscler Thromb Vasc Biol (1999) 1.39
Bench to bedside: nitric oxide in emergency medicine. Acad Emerg Med (2000) 1.39
The role of MKK1/2 kinase activity in human cytomegalovirus infection. J Gen Virol (2001) 1.35
The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation (1992) 1.28
Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J Clin Invest (1997) 1.24
Integrins regulate the intracellular distribution of eukaryotic initiation factor 4E in platelets. A checkpoint for translational control. J Biol Chem (2001) 1.24
Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin. Am J Physiol Endocrinol Metab (2001) 1.23
Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J Pharmacol Exp Ther (1992) 1.22
Integrin-dependent control of translation: engagement of integrin alphaIIbbeta3 regulates synthesis of proteins in activated human platelets. J Cell Biol (1999) 1.21
Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC-SIGN and caspases. J Thromb Haemost (2013) 1.21
Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol. Circ Res (1998) 1.15
The septic milieu triggers expression of spliced tissue factor mRNA in human platelets. J Thromb Haemost (2011) 1.15
Method of acetaldehyde measurement with minimal artifactual formation in red blood cells and plasma of actively drinking subjects with alcoholism. J Lab Clin Med (1992) 1.14
Monoclonal antibody to L-selectin attenuates neutrophil accumulation and protects ischemic reperfused cat myocardium. Circulation (1993) 1.13
A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid. Br J Pharmacol (2001) 1.13
Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules. J Clin Invest (1997) 1.12
Nitric oxide protects against leukocyte-endothelium interactions in the early stages of hypercholesterolemia. Arterioscler Thromb Vasc Biol (1995) 1.12
Cell adhesion regulates gene expression at translational checkpoints in human myeloid leukocytes. Proc Natl Acad Sci U S A (2001) 1.12
Local decomposition induced by dislocation motions inside precipitates in an Al-alloy. Sci Rep (2013) 1.12
Thioredoxin reduces post-ischemic myocardial apoptosis by reducing oxidative/nitrative stress. Br J Pharmacol (2006) 1.11
Myocardial ischemia/reperfusion injury in NADPH oxidase-deficient mice. Circ Res (2000) 1.10
Role of selectins, a new family of adhesion molecules, in ischaemia-reperfusion injury. Cardiovasc Res (1994) 1.09
Decreased basal nitric oxide release in hypercholesterolemia increases neutrophil adherence to rabbit coronary artery endothelium. Arterioscler Thromb (1993) 1.08
Differential regulation of matrix metalloproteinase-9 by monocytes adherent to collagen and platelets. Circ Res (2001) 1.07
Role of ERK1/2 in the anti-apoptotic and cardioprotective effects of nitric oxide after myocardial ischemia and reperfusion. Apoptosis (2006) 1.06
Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease. Cardiovasc Res (2001) 1.06
Direct measurement of nitric oxide release from vascular endothelial cells. J Appl Physiol (1985) (1996) 1.05
Endothelial dysfunction and neutrophil adherence as critical events in the development of reperfusion injury. Agents Actions Suppl (1993) 1.04
Peroxynitrite reduces myocardial infarct size and preserves coronary endothelium after ischemia and reperfusion in cats. Circulation (1997) 1.04
Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle. Circ Res (1994) 1.02
Lysophosphatidylcholine promotes P-selectin expression in platelets and endothelial cells. Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors. Circ Res (1996) 1.02
Rapid restoration of normal endothelial functions in genetically hyperlipidemic mice by a synthetic mediator of reverse lipid transport. Arterioscler Thromb Vasc Biol (2000) 1.01
Beneficial effects of SPM-5185, a cysteine-containing NO donor in myocardial ischemia-reperfusion. Am J Physiol (1992) 1.01
Fluid flow activates a regulator of translation, p70/p85 S6 kinase, in human endothelial cells. Am J Physiol Heart Circ Physiol (2000) 1.01
Recombinant soluble P-selectin glycoprotein ligand-1 protects against myocardial ischemic reperfusion injury in cats. Cardiovasc Res (1999) 0.99
Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion: role of selectins. Circulation (1998) 0.98
Nitrate tolerance aggravates postischemic myocardial apoptosis and impairs cardiac functional recovery after ischemia. Apoptosis (2005) 0.97
HMG-CoA reductase inhibition protects the diabetic myocardium from ischemia-reperfusion injury. FASEB J (2001) 0.96
Antishock and endothelial protective actions of a NO donor in mesenteric ischemia and reperfusion. Circ Shock (1992) 0.96
Role of nitric oxide in the regulation of acute and chronic inflammation. Antioxid Redox Signal (2000) 0.96
Homocysteine provokes leukocyte-endothelium interaction by downregulation of nitric oxide. Gen Pharmacol (1999) 0.96
Association between use of benzodiazepines and risk of fractures: a meta-analysis. Osteoporos Int (2013) 0.95
PR-39, a potent neutrophil inhibitor, attenuates myocardial ischemia-reperfusion injury in mice. Am J Physiol Heart Circ Physiol (2000) 0.95
Mechanisms of cardioprotection by peroxynitrite in myocardial ischemia and reperfusion injury. Am J Physiol (1998) 0.94
Mechanisms of the cardioprotective actions of WEB-2170, bepafant, a platelet activating factor antagonist, in myocardial ischemia and reperfusion. J Pharmacol Exp Ther (1992) 0.94
Cytokines and growth factors in endothelial dysfunction. Crit Care Med (1993) 0.94
Ratings of perceived exertion in individuals with varying fitness levels during walking and running. Eur J Appl Physiol Occup Physiol (1989) 0.92
Sialyl Lewisx-containing oligosaccharide attenuates myocardial reperfusion injury in cats. J Clin Invest (1994) 0.92
Peroxynitrite, the product of nitric oxide and superoxide, causes myocardial injury in the isolated perfused rat heart. Coron Artery Dis (1997) 0.92
Anti-apoptotic effect of benidipine, a long-lasting vasodilating calcium antagonist, in ischaemic/reperfused myocardial cells. Br J Pharmacol (2001) 0.91
C-peptide exerts cardioprotective effects in myocardial ischemia-reperfusion. Am J Physiol Heart Circ Physiol (2000) 0.91
Wortmannin, a potent antineutrophil agent, exerts cardioprotective effects in myocardial ischemia/reperfusion. J Pharmacol Exp Ther (2000) 0.91
Recombinant human complement C5a receptor antagonist reduces infarct size after surgical revascularization. J Thorac Cardiovasc Surg (2000) 0.88
Early anti-apoptosis treatment reduces myocardial infarct size after a prolonged reperfusion. Apoptosis (2004) 0.87
Role of insulin in the anti-apoptotic effect of glucose-insulin-potassium in rabbits with acute myocardial ischemia and reperfusion. Apoptosis (2004) 0.87
Protective actions of a leukotriene B4 antagonist in splanchnic ischemia and reperfusion in rats. Am J Physiol (1991) 0.86
Anti-ischaemic and endothelial protective actions of recombinant human osteogenic protein (hOP-1). J Mol Cell Cardiol (1992) 0.86
PR-39, a proline/arginine-rich antimicrobial peptide, exerts cardioprotective effects in myocardial ischemia-reperfusion. Cardiovasc Res (2001) 0.86
Cardioprotective effect of interleukin-10 in murine myocardial ischemia-reperfusion. Eur J Pharmacol (1997) 0.85
Time course of endothelial dysfunction and myocardial injury during coronary arterial occlusion. Am J Physiol (1991) 0.84
Coengagement of ICAM-3 and Fc receptors induces chemokine secretion and spreading by myeloid leukocytes. J Immunol (1998) 0.83
Ventilatory responses of trained and untrained subjects during running and walking. Int J Sports Med (1988) 0.83
S-nitrosylated tissue-type plasminogen activator protects against myocardial ischemia/reperfusion injury in cats: role of the endothelium. J Pharmacol Exp Ther (1996) 0.83
Local decomposition induced by dislocation motions inside tetragonal Al(2)Cu compound: slip system-dependent dynamics. Sci Rep (2013) 0.83
Beneficial effects of transforming growth factor-beta and tissue plasminogen activator in splanchnic artery occlusion and reperfusion in cats. J Cardiovasc Pharmacol (1991) 0.83
Protein degradation systems in platelets. Thromb Haemost (2013) 0.83
Cardioprotective and endothelial protective effects of [Ala-IL8]77 in a rabbit model of myocardial ischaemia and reperfusion. Br J Pharmacol (1991) 0.83
Heme oxygenase inhibitor zinc protoporphyrin IX causes an activation of nitric oxide synthase in the rabbit internal anal sphincter. J Pharmacol Exp Ther (1996) 0.83
Humanized monoclonal antibody DREG-200 directed against I-selectin protects in feline myocardial reperfusion injury. J Pharmacol Exp Ther (1994) 0.82
Protection of ischemia-reperfusion injury by sydnonimine NO donors via inhibition of neutrophil-endothelium interaction. J Cardiovasc Pharmacol (1993) 0.82
Expressed sequence tags from a NaCl-treated Suaeda salsa cDNA library. Gene (2001) 0.82
Splanchnic vascular endothelial dysfunction in rat endotoxemia: role of superoxide radicals. Eur J Pharmacol (1992) 0.82
Carvedilol inhibits activation of stress-activated protein kinase and reduces reperfusion injury in perfused rabbit heart. Eur J Pharmacol (1998) 0.82
SP/W-5186, A cysteine-containing nitric oxide donor, attenuates postischemic myocardial injury. J Pharmacol Exp Ther (1998) 0.81
[The effects of Panax quinquefolium saponin (PQS) and its monomer ginsenoside on heart]. Zhongguo Zhong Yao Za Zhi (1994) 0.81
Estrogen alone or in combination with parathyroid hormone can decrease vertebral MEF2 and sclerostin expression and increase vertebral bone mass in ovariectomized rats. Osteoporos Int (2014) 0.81
Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model. Eur J Pharmacol (2000) 0.80
Isolated cardiac myocytes are sensitized by hypoxia-reoxygenation to neutrophil-released mediators. Am J Physiol (1994) 0.80
Mechanism of decreased adenosine protection in reperfusion injury of aging rats. Am J Physiol Heart Circ Physiol (2000) 0.80
Gender differences in the response of hepatic fatty acids and cytosolic fatty acid-binding capacity to alcohol consumption in rats. Proc Soc Exp Biol Med (1991) 0.80
Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model. Eur J Pharmacol (1998) 0.79
Sequential nitric oxide measurements during the emergency department treatment of acute vasoocclusive sickle cell crisis. Am J Hematol (2000) 0.79
Beneficial effects of C1 esterase inhibitor in murine traumatic shock. Shock (1997) 0.79
Shock- and ischemia-induced mechanisms of impairment of endothelium-mediated vasodilation. Chest (1991) 0.79
Endothelial stunning and myocyte recovery after reperfusion of jeopardized muscle: a role of L-arginine blood cardioplegia. J Thorac Cardiovasc Surg (1997) 0.79
Quantification of neutrophil migration following myocardial ischemia and reperfusion in cats and dogs. J Leukoc Biol (1994) 0.79